PL2898886T3 - Kompozycja farmaceutyczna do podawania doustnego z polepszoną elucją i/lub wchłanianiem - Google Patents
Kompozycja farmaceutyczna do podawania doustnego z polepszoną elucją i/lub wchłanianiemInfo
- Publication number
- PL2898886T3 PL2898886T3 PL13839200T PL13839200T PL2898886T3 PL 2898886 T3 PL2898886 T3 PL 2898886T3 PL 13839200 T PL13839200 T PL 13839200T PL 13839200 T PL13839200 T PL 13839200T PL 2898886 T3 PL2898886 T3 PL 2898886T3
- Authority
- PL
- Poland
- Prior art keywords
- absorbency
- pharmaceutical composition
- oral administration
- improved elution
- elution
- Prior art date
Links
- 238000010828 elution Methods 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pulmonology (AREA)
- Neurology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2012205681 | 2012-09-19 | ||
| EP13839200.6A EP2898886B1 (en) | 2012-09-19 | 2013-09-18 | Pharmaceutical composition for oral administration with improved elution and/or absorbency |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2898886T3 true PL2898886T3 (pl) | 2017-06-30 |
Family
ID=50341439
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL13839200T PL2898886T3 (pl) | 2012-09-19 | 2013-09-18 | Kompozycja farmaceutyczna do podawania doustnego z polepszoną elucją i/lub wchłanianiem |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US9555115B2 (pl) |
| EP (1) | EP2898886B1 (pl) |
| JP (1) | JP5791817B2 (pl) |
| KR (1) | KR101609105B1 (pl) |
| CN (1) | CN104640547B (pl) |
| AU (1) | AU2013319118B2 (pl) |
| BR (1) | BR112015005489B1 (pl) |
| CA (1) | CA2884731C (pl) |
| DK (1) | DK2898886T3 (pl) |
| ES (1) | ES2622585T3 (pl) |
| HU (1) | HUE032635T2 (pl) |
| MX (1) | MX345435B (pl) |
| MY (1) | MY183976A (pl) |
| PL (1) | PL2898886T3 (pl) |
| PT (1) | PT2898886T (pl) |
| RU (1) | RU2589701C1 (pl) |
| SG (1) | SG11201501043TA (pl) |
| TW (1) | TWI536992B (pl) |
| WO (1) | WO2014046129A1 (pl) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI707851B (zh) * | 2015-09-17 | 2020-10-21 | 日商大鵬藥品工業股份有限公司 | 哌嗪化合物的新穎結晶 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3237575A1 (de) | 1982-10-09 | 1984-04-12 | Dr. Karl Thomae Gmbh, 7950 Biberach | Neue orale mopidamolformen |
| JP4292588B2 (ja) * | 1997-01-31 | 2009-07-08 | 日産化学工業株式会社 | ピリダジノン化合物類の経口製剤 |
| TW482675B (en) | 1997-01-31 | 2002-04-11 | Green Cross Corp | Compositions for oral administration containing pyridazinone compounds technical field of the invention |
| JP3797764B2 (ja) * | 1997-10-01 | 2006-07-19 | エーザイ株式会社 | 光安定化組成物 |
| HUP0400639A3 (en) * | 2000-12-21 | 2010-03-29 | Vertex Pharma | Pyrazole compounds useful as protein kinase inhibitors and pharmaceutical compositions containing them |
| WO2002087621A1 (en) | 2001-04-30 | 2002-11-07 | Shire Laboratories Inc. | Pharmaceutical composition including ace/nep inhibitors and bioavailability enhancers |
| JP2003252762A (ja) * | 2001-12-25 | 2003-09-10 | Takeda Chem Ind Ltd | 酸配合製剤 |
| WO2003055525A1 (fr) | 2001-12-25 | 2003-07-10 | Takeda Chemical Industries, Ltd. | Preparations contenant un acide |
| DE10209982A1 (de) * | 2002-03-07 | 2003-09-25 | Boehringer Ingelheim Pharma | Oral zu applizierende Darreichungsform für schwerlösliche basische Wirkstoffe |
| DE10337697A1 (de) | 2003-08-16 | 2005-03-24 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Tablette enthaltend 3-[(2-{[4-(Hexyloxycarbonylamino-imino-methyl)-phenyl-amino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionsäure-ethylester oder dessen Salze |
| JP4572293B2 (ja) * | 2004-07-21 | 2010-11-04 | トーアエイヨー株式会社 | ピモベンダン経口投与製剤 |
| ES2953390T3 (es) * | 2006-08-31 | 2023-11-10 | Adare Pharmaceuticals Inc | Sistemas de administración de fármacos que comprenden disoluciones sólidas de fármacos débilmente básicos |
| WO2008123536A1 (en) | 2007-03-28 | 2008-10-16 | Takeda Pharmaceutical Company Limited | Solid pharmaceutical composition comprising a benzimidazole-7-carboxylate derivative and a ph control agent |
| WO2008143240A1 (ja) * | 2007-05-21 | 2008-11-27 | Toray Industries, Inc. | 特定の有機酸を含有する経口製剤並びに経口製剤の溶出性及び化学的安定性の改善方法 |
| JP2011522006A (ja) | 2008-06-04 | 2011-07-28 | アストラゼネカ アクチボラグ | 新規化合物v |
| TW201010992A (en) | 2008-07-28 | 2010-03-16 | Takeda Pharmaceutical | Pharmaceutical composition |
| WO2010100759A1 (ja) | 2009-03-06 | 2010-09-10 | トヨタ自動車株式会社 | 運転支援装置 |
| CN102341385B (zh) * | 2009-03-09 | 2014-01-15 | 大鹏药品工业株式会社 | 能够抑制前列腺素d合酶的哌嗪化合物 |
-
2013
- 2013-09-18 HU HUE13839200A patent/HUE032635T2/en unknown
- 2013-09-18 TW TW102133892A patent/TWI536992B/zh active
- 2013-09-18 KR KR1020157009713A patent/KR101609105B1/ko active Active
- 2013-09-18 PT PT138392006T patent/PT2898886T/pt unknown
- 2013-09-18 CN CN201380048719.6A patent/CN104640547B/zh active Active
- 2013-09-18 SG SG11201501043TA patent/SG11201501043TA/en unknown
- 2013-09-18 US US14/423,750 patent/US9555115B2/en active Active
- 2013-09-18 CA CA2884731A patent/CA2884731C/en active Active
- 2013-09-18 EP EP13839200.6A patent/EP2898886B1/en active Active
- 2013-09-18 MX MX2015003410A patent/MX345435B/es active IP Right Grant
- 2013-09-18 DK DK13839200.6T patent/DK2898886T3/en active
- 2013-09-18 AU AU2013319118A patent/AU2013319118B2/en active Active
- 2013-09-18 ES ES13839200.6T patent/ES2622585T3/es active Active
- 2013-09-18 MY MYPI2015700813A patent/MY183976A/en unknown
- 2013-09-18 PL PL13839200T patent/PL2898886T3/pl unknown
- 2013-09-18 JP JP2014536878A patent/JP5791817B2/ja active Active
- 2013-09-18 WO PCT/JP2013/075157 patent/WO2014046129A1/ja not_active Ceased
- 2013-09-18 BR BR112015005489-7A patent/BR112015005489B1/pt active IP Right Grant
- 2013-09-18 RU RU2015114567/15A patent/RU2589701C1/ru active
Also Published As
| Publication number | Publication date |
|---|---|
| EP2898886A1 (en) | 2015-07-29 |
| CA2884731C (en) | 2016-11-01 |
| CN104640547A (zh) | 2015-05-20 |
| US9555115B2 (en) | 2017-01-31 |
| PT2898886T (pt) | 2017-03-23 |
| JPWO2014046129A1 (ja) | 2016-08-18 |
| BR112015005489A2 (pt) | 2017-07-04 |
| ES2622585T3 (es) | 2017-07-06 |
| EP2898886B1 (en) | 2017-02-15 |
| TW201414476A (zh) | 2014-04-16 |
| DK2898886T3 (en) | 2017-03-27 |
| BR112015005489B1 (pt) | 2022-07-12 |
| HK1207969A1 (en) | 2016-02-19 |
| MX2015003410A (es) | 2015-06-04 |
| JP5791817B2 (ja) | 2015-10-07 |
| MY183976A (en) | 2021-03-17 |
| CN104640547B (zh) | 2017-07-11 |
| KR101609105B1 (ko) | 2016-04-04 |
| RU2589701C1 (ru) | 2016-07-10 |
| US20150297722A1 (en) | 2015-10-22 |
| CA2884731A1 (en) | 2014-03-27 |
| WO2014046129A1 (ja) | 2014-03-27 |
| MX345435B (es) | 2017-01-30 |
| EP2898886A4 (en) | 2016-04-27 |
| HUE032635T2 (en) | 2017-10-30 |
| AU2013319118A1 (en) | 2015-03-12 |
| SG11201501043TA (en) | 2015-04-29 |
| TWI536992B (zh) | 2016-06-11 |
| AU2013319118B2 (en) | 2016-03-03 |
| KR20150056827A (ko) | 2015-05-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL274988A (en) | Carbamoylpyridone-polycyclic compounds and their pharmaceutical use | |
| ZA201406233B (en) | Pharmaceutical composition and administration thereof | |
| IL236024A (en) | The history of benzimidazole-proline and its pharmaceutical preparations | |
| SG11201403875VA (en) | Oral pharmaceutical composition | |
| ZA201306395B (en) | New low side effect pharmaceutical composition containing antituberculosis drugs | |
| ZA201409508B (en) | Pharmaceutical composition comprising fimasartan and hydrochlorothiazide | |
| GB2504390B (en) | Nutraceutical and pharmaceutical composition | |
| ZA201302012B (en) | Low dose pharmaceutical composition | |
| ZA201504512B (en) | Pharmaceutical composition comprising desloratadine and prednisolone and use thereof | |
| IL235947A0 (en) | History of isonicotinamide in solid state and pharmaceutical preparations containing them | |
| ZA201400340B (en) | Pharmaceutical composition comprising ebastine and fluticasone | |
| PT2415463E (pt) | Composição medicinal em partículas | |
| PT2898886T (pt) | Composição farmacêutica para administração oral apresentando uma melhor eluição e/ou uma melhor capacidade de absorção | |
| EP2979698A4 (en) | PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION | |
| EP2529755A4 (en) | PHARMACEUTICAL COMPOSITION AND PREPARATION THEREFOR FOR ORAL ADMINISTRATION | |
| IL233983A0 (en) | History of thiazolidinones, their preparation and pharmaceutical preparations containing them | |
| IL234614B (en) | Pharmaceutical composition and preparation method thereof | |
| GB201112578D0 (en) | Pharmaceutical preparation and use |